Results 51 to 60 of about 11,862,011 (403)
THE TREATMENT OF PSORIASIS WITH MYELOCENE. [PDF]
n ...
Watson, D. Chalmers+1 more
openaire +3 more sources
Biosimilar Agents for Psoriasis Treatment: The Perspective of Portuguese Patients.
INTRODUCTION Biosimilars are highly similar copies of previously approved original biologic medicines. Their introduction on the market may yield cost reduction.
A. Azevedo+3 more
semanticscholar +1 more source
The Safety of Systemic Treatments That Can Be Used for Geriatric Psoriasis Patients: A Review
Background. Patients with moderate-to-severe psoriasis are often treated with systemic immunosuppressant agents that decrease immune system function. For the elderly, these medications are often problematic due to their already immunosuppressed state and
Jillian W. Wong, John Y. M. Koo
doaj +1 more source
Psoriasis is an inflammatory dermatosis manifested by the appearance of brown-red papules on the body, covered with silver scales. One of the most common and effective treatments for psoriasis is narrow-band UVB phototherapy.
Wiktoria Odrzywołek+5 more
doaj +1 more source
Validating a Selective S1P1 Receptor Modulator Syl930 for Psoriasis Treatment.
Psoriasis is a chronic inflammatory skin disease characterized by red, scaly and raised plaques. Thus far, T-cell infiltration is one of the most prominent pathogenic triggers, however, the exact molecular mechanisms underlying psoriasis have not been ...
M. Ji+7 more
semanticscholar +1 more source
Clinical consequences of antibody formation, serum concentrations, and HLA-Cw6 status in psoriasis patients on Ustekinumab [PDF]
Background: Ustekinumab for the treatment of psoriasis is currently administered in a standard dosing regimen. However, some patients tend to benefit from alternative dosing regimens, a step toward personalized medicine.
Busard, Celine, I+9 more
core +1 more source
Objectives Psoriasis‐related pruritus is a frequent and underestimated symptom with a strong impact on quality of life, psychological condition and sleep.
Laurent Misery+4 more
doaj +1 more source
Long-term follow-up of 22 psoriatic patients treated with ixekizumab after failure of secukinumab [PDF]
Switching of biologic agents in treatment of plaque psoriasis is a common strategy. Only a few studies are available on switching between IL17A-blockers.
Amschler, K+6 more
core +1 more source
JAK3 as an emerging target for topical treatment of inflammatory skin diseases [PDF]
The recent interest and elucidation of the JAK/STAT signaling pathway created new targets for the treatment of inflammatory skin diseases (ISDs). JAK inhibitors in oral and topical formulations have shown beneficial results in psoriasis and alopecia ...
Alves de Medeiros, Ana+5 more
core +2 more sources
The risk of developing psoriasis in alcohol-dependent patients and possible therapeutic strategies
Excessive alcohol consumption significantly contributes to the damage of the nervous, cardiovascular and digestive systems. According to the latest scientific reports, excessive ethanol consumption might also contribute to an increased risk of developing
Iga Dudek+7 more
doaj +1 more source